E10 Choice of Control Group and Related Issues in Clinical Trials
Detailed guidance document from FDA and regulatory agencies.
Document Details
Guidance Document
May 14, 2001
April 29, 2020
c5fec9b1-2f5e-4a87-9fda-d276bbfb5cbb
Related Documents
E2E Pharmacovigilance Planning
Guidance DocumentApril 1, 2005Center for Drug Evaluation and Research
IND Meetings for Human Drugs and Biologics Chemistry, Manufacturing, and Controls Information: Guidance for Industry
Guidance DocumentMay 1, 2001Center for Drug Evaluation and Research
S7A Safety Pharmacology Studies for Human Pharmaceuticals
Guidance DocumentJuly 13, 2001Center for Drug Evaluation and Research
Quick Actions
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.
Try KeyPedia Today
Explore our real use cases and discover our features in depth.
Subscribe to our newsletter
Get the latest updates and insights delivered to your inbox